- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccination in the immunotherapy of glioblastoma
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 14, Issue 2, Pages 255-268
Publisher
Informa UK Limited
Online
2017-11-01
DOI
10.1080/21645515.2017.1388481
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prospect of rindopepimut in the treatment of glioblastoma
- (2017) Aladine A. Elsamadicy et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
- (2017) Susana Inogés et al. Journal of Translational Medicine
- Immune microenvironment of gliomas
- (2017) Anna Gieryng et al. LABORATORY INVESTIGATION
- The heat-shock protein/chaperone network and multiple stress resistance
- (2017) Pierre Jacob et al. PLANT BIOTECHNOLOGY JOURNAL
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy
- (2016) Anirudh Saraswathula et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma
- (2016) Robert A. Fenstermaker et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CGCG clinical practice guidelines for the management of adult diffuse gliomas
- (2016) Tao Jiang et al. CANCER LETTERS
- CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells
- (2016) Alan L. Chang et al. CANCER RESEARCH
- Survival in glioblastoma: a review on the impact of treatment modalities
- (2016) P. D. Delgado-López et al. Clinical & Translational Oncology
- A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma
- (2016) R. Rampling et al. CLINICAL CANCER RESEARCH
- Adoptive immunotherapy for the treatment of glioblastoma: progress and possibilities
- (2016) Shunichiro Kuramitsu et al. Immunotherapy
- The present status and future prospects of peptide-based cancer vaccines
- (2016) Masatoshi Hirayama et al. INTERNATIONAL IMMUNOLOGY
- Diffuse Intrinsic Pontine Glioma
- (2016) Tammy Hennika et al. JOURNAL OF CHILD NEUROLOGY
- Outcome in unresectable glioblastoma: MGMT promoter methylation makes the difference
- (2016) Niklas Thon et al. JOURNAL OF NEUROLOGY
- Hematopoietic stem cells as a tool for the treatment of glioblastoma multiforme
- (2016) Igor S. Bryukhovetskiy et al. Molecular Medicine Reports
- ATIM-03. ACT IV: AN INTERNATIONAL, DOUBLE-BLIND, PHASE 3 TRIAL OF RINDOPEPIMUT IN NEWLY DIAGNOSED, EGFRvIII-EXPRESSING GLIOBLASTOMA
- (2016) Michael Weller et al. NEURO-ONCOLOGY
- Epidemiology of Brain Tumors
- (2016) Katharine A. McNeill NEUROLOGIC CLINICS
- Peptide vaccination therapy: Towards the next generation
- (2016) Tomohide Tsukahara et al. PATHOLOGY INTERNATIONAL
- Heat Shock Proteins Promote Cancer: It's a Protection Racket
- (2016) Stuart K. Calderwood et al. TRENDS IN BIOCHEMICAL SCIENCES
- The Janus Face of Death Receptor Signaling during Tumor Immunoediting
- (2016) Eimear O’ Reilly et al. Frontiers in Immunology
- Heat Shock Protein–Peptide and HSP-Based Immunotherapies for the Treatment of Cancer
- (2016) Maxim Shevtsov et al. Frontiers in Immunology
- Adjuvants for peptide-based cancer vaccines
- (2016) Hiep Khong et al. Journal for ImmunoTherapy of Cancer
- Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model
- (2016) Mao Ouyang et al. PLoS One
- Conformational Nanobodies Reveal Tethered Epidermal Growth Factor Receptor Involved in EGFR/ErbB2 Predimers
- (2015) Damien Nevoltris et al. ACS Nano
- A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma
- (2015) Manfred Westphal et al. EUROPEAN JOURNAL OF CANCER
- Progression-free and overall survival in patients with recurrent Glioblastoma multiforme treated with last-line bevacizumab versus bevacizumab/lomustine
- (2015) D. H. Heiland et al. JOURNAL OF NEURO-ONCOLOGY
- Heat shock protein vaccines against glioblastoma: from bench to bedside
- (2015) Leonel Ampie et al. JOURNAL OF NEURO-ONCOLOGY
- Dendritic cell–based immunotherapy targeting Wilms’ tumor 1 in patients with recurrent malignant glioma
- (2015) Keiichi Sakai et al. JOURNAL OF NEUROSURGERY
- Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
- (2015) Duane A. Mitchell et al. NATURE
- Integrated genomic characterization of IDH1-mutant glioma malignant progression
- (2015) Hanwen Bai et al. NATURE GENETICS
- IMCT-08ReACT: LONG-TERM SURVIVAL FROM A RANDOMIZED PHASE II STUDY OF RINDOPEPIMUT (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA
- (2015) David A. Reardon et al. NEURO-ONCOLOGY
- A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
- (2015) J. Schuster et al. NEURO-ONCOLOGY
- PD-L1 expression and prognostic impact in glioblastoma
- (2015) Edjah K. Nduom et al. NEURO-ONCOLOGY
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Directional migration of adult hematopoeitic progenitors to C6 glioma in vitro
- (2015) IGOR STEPANOVICH BRYUKHOVETSKIY et al. Oncology Letters
- The progress of immunotherapy for glioblastoma
- (2015) Qiangyi Zhou et al. Human Vaccines & Immunotherapeutics
- Tumor stroma and chemokines control T-cell migration into melanoma following Temozolomide treatment
- (2015) Kar Wai Tan et al. OncoImmunology
- Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation
- (2015) Yafei Hou et al. Journal for ImmunoTherapy of Cancer
- To the Novel Paradigm of Proteome-Based Cell Therapy of Tumors: Through Comparative Proteome Mapping of Tumor Stem Cells and Tissue-Specific Stem Cells of Humans
- (2014) Andrey Bryukhovetskiy et al. CELL TRANSPLANTATION
- Heat Shock Proteins as Prognostic Markers of Cancer
- (2014) Evgeniya Kaigorodova et al. CURRENT CANCER DRUG TARGETS
- Heat-shock proteins-based immunotherapy for advanced melanoma in the era of target therapies and immunomodulating agents
- (2014) Giulio Tosti et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Development and Function of Dendritic Cell Subsets
- (2014) Alexander Mildner et al. IMMUNITY
- Effective immunotherapy of rat glioblastoma with prolonged intratumoral delivery of exogenous heat shock protein Hsp70
- (2014) Maxim A. Shevtsov et al. INTERNATIONAL JOURNAL OF CANCER
- Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme
- (2014) Martin K. Hunn et al. JOURNAL OF NEURO-ONCOLOGY
- Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma
- (2014) Eiichi Ishikawa et al. JOURNAL OF NEUROSURGERY
- A vaccine targeting mutant IDH1 induces antitumour immunity
- (2014) Theresa Schumacher et al. NATURE
- CTL responses to HSP47 associated with the prolonged survival of patients with glioblastomas
- (2014) Z. B. Wu et al. NEUROLOGY
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fas, FasL, and cleaved caspases 8 and 3 in glioblastomas: A tissue microarray-based study
- (2014) Fabiano P. Saggioro et al. PATHOLOGY RESEARCH AND PRACTICE
- Afferent and efferent immunological pathways of the brain. Anatomy, Function and Failure
- (2013) R.O. Carare et al. BRAIN BEHAVIOR AND IMMUNITY
- Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
- (2013) Einar Osland Vik-Mo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
- (2013) Mark R. Gilbert et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of Glioma-associated Antigen Peptide-loaded Versus Autologous Tumor Lysate-loaded Dendritic Cell Vaccination in Malignant Glioma Patients
- (2013) Robert M. Prins et al. JOURNAL OF IMMUNOTHERAPY
- Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial
- (2013) Orin Bloch et al. NEURO-ONCOLOGY
- Human Leukocyte Antigen-G Is Frequently Expressed in Glioblastoma and May Be Induced in Vitro by Combined 5-Aza-2′-Deoxycytidine and Interferon-γ Treatments
- (2012) Isabela J. Wastowski et al. AMERICAN JOURNAL OF PATHOLOGY
- α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
- (2012) Yasuto Akiyama et al. BMC CANCER
- Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
- (2012) Hilko Ardon et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
- (2012) Surasak Phuphanich et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Individual Patient-Specific Immunity against High-Grade Glioma after Vaccination with Autologous Tumor Derived Peptides Bound to the 96 KD Chaperone Protein
- (2012) C. A. Crane et al. CLINICAL CANCER RESEARCH
- New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: A pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials
- (2012) Thierry Gorlia et al. EUROPEAN JOURNAL OF CANCER
- A Pilot Study of IL-2Rα Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma
- (2012) John H. Sampson et al. PLoS One
- Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
- (2011) A. G. Sorensen et al. CANCER RESEARCH
- Clinical Application of a Dendritic Cell Vaccine Raised Against Heat-Shocked Glioblastoma
- (2011) X. Jie et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Heat shock protein–peptide complex in the treatment of glioblastoma
- (2011) Alfred P See et al. Expert Review of Vaccines
- A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma
- (2011) Chen-Nen Chang et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy
- (2011) Camilo E. Fadul et al. JOURNAL OF IMMUNOTHERAPY
- Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?
- (2011) J. L. Clarke et al. NEURO-ONCOLOGY
- Postoperative Infection May Influence Survival in Patients With Glioblastoma: Simply a Myth?
- (2011) Pasquale De Bonis et al. NEUROSURGERY
- Adjuvant Immunotherapy with Whole-Cell Lysate Dendritic Cells Vaccine for Glioblastoma Multiforme: A Phase II Clinical Trial
- (2011) Der-Yang Cho et al. World Neurosurgery
- Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy
- (2010) Robert M. Prins et al. CLINICAL CANCER RESEARCH
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
- (2010) John H. Sampson et al. JOURNAL OF CLINICAL ONCOLOGY
- Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study
- (2010) Hilko Ardon et al. JOURNAL OF NEURO-ONCOLOGY
- A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma
- (2010) M. R. Rosenfeld et al. NEURO-ONCOLOGY
- Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
- (2010) J. H. Sampson et al. NEURO-ONCOLOGY
- Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: An unexpected prognostic significance?
- (2010) Leos Kren et al. NEUROPATHOLOGY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vitespen: a preclinical and clinical review
- (2009) Christopher G Wood et al. Future Oncology
- Bacillus Calmette–Guerin immunotherapy for urothelial carcinoma of the bladder
- (2009) Timothy P Kresowik et al. Immunotherapy
- An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
- (2009) J. H. Sampson et al. MOLECULAR CANCER THERAPEUTICS
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccination Elicits Correlated Immune and Clinical Responses in Glioblastoma Multiforme Patients
- (2008) C. J. Wheeler et al. CANCER RESEARCH
- Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines
- (2008) Robert J. Schmittling et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Microglia: gatekeepers of central nervous system immunology
- (2008) Bart R. Tambuyzer et al. JOURNAL OF LEUKOCYTE BIOLOGY
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
- Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy
- (2007) David G. Walker et al. JOURNAL OF CLINICAL NEUROSCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started